News

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
Shares of Eli Lilly took a 14% hit earlier this month ... On Tuesday, a new potential GLP-1 competitor from Viking Therapeutics revealed its own trial problems. It’s easy for good news to move the ...